CD51 抗体
(Integrin alpha V (ITGAV))
ITAGV encodes integrin alpha chain V. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain. The I-domain containing integrin alpha V undergoes post-translational cleavage to yield disulfide-linked heavy and light chains, that combine with multiple integrin beta chains to form different integrins. Among the known associating beta chains (beta chains 1,3,5,6, and 8\; 'ITGB1', 'ITGB3', 'ITGB5', 'ITGB6', and 'ITGB8'), each can interact with extracellular matrix ligands\; the alpha V beta 3 integrin, perhaps the most studied of these, is referred to as the Vitronectin receptor (VNR). In addition to adhesion, many integrins are known to facilitate signal transduction. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2009].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| CD51 抗体 | 人 | 兔 Monoclonal |
|
|
|
| Recombinant CD51 抗体 | 人 | 兔 Monoclonal |
|
|
|
| CD51 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| CD51 抗体 (AA 775-885) | 人 | 兔 Polyclonal |
|
|
|
| CD51 抗体 (AA 560-744) | 人 | 兔 Polyclonal |
|
|
|
| CD51 抗体 (AA 51-150) | 人 | 兔 Polyclonal |
|
|
|
| CD51 抗体 | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| Recombinant CD51 抗体 | 人 | 兔 Monoclonal |
|
|
|
| Recombinant CD51 抗体 | 人 | 兔 Monoclonal |
|
|
|
| CD51 抗体 (C-Term) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| CD51 抗体 (AA 71-322) | 小鼠 | 兔 Polyclonal |
|
|
|
| CD51 抗体 (AA 1-1048) | 人 | 小鼠 Polyclonal |
|
|
|
| CD51 抗体 (AA 1-1048) | 人 | 兔 Polyclonal |
|
|
|
| CD51 抗体 | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| CD51 抗体 (Cleaved-Lys889) | 人 | 兔 Polyclonal |
|
|
|
| CD51 抗体 (Cleaved-Lys889) | 人 | 兔 Polyclonal |
|
|
|
| Recombinant CD51 抗体 | 人 | 兔 Monoclonal |
|
|
|
| Recombinant CD51 抗体 | 人 | 兔 Monoclonal |
|
|
|
| CD51 抗体 | 人 | 兔 Polyclonal |
|
|
|
| CD51 抗体 (AA 1-1048) | 人 | 小鼠 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- ICC (Immunocytochemistry: 有验证图片)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 质量等级
- KD Validated
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- 23GB2240
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IP (Immunoprecipitation: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 775-885
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 560-744
Primary Antibody
- FACS (Flow Cytometry: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
3 references - 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 51-150
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- 质量等级
- KD Validated
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- 24GB4430
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- 质量等级
- KD Validated
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- 24GB4435
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 71-322
Primary Antibody
- WB (Western Blotting: 有验证图片)
- PLA (Proximity Ligation Assay: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-1048
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-1048
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- Cleaved-Lys889
Primary Antibody
- IHC (fp) (Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections): 有验证图片)
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 840-889, Cleaved-Lys889
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- 4G7
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- 5G3
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-1048
Latest Publications for our CD51 抗体
: "Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target." in: The Journal of clinical investigation, Vol. 129, Issue 1, pp. 137-149, (2019) (PubMed).
: "GSH-sensitive Pt(IV) prodrug-loaded phase-transitional nanoparticles with a hybrid lipid-polymer shell for precise theranostics against ovarian cancer." in: Theranostics, Vol. 9, Issue 4, pp. 1047-1065, (2019) (PubMed).
: "β8 Integrin Mediates Pancreatic Cancer Cell Radiochemoresistance." in: Molecular cancer research : MCR, (2019) (PubMed).
: "The post-abscission midbody is an intracellular signaling organelle that regulates cell proliferation." in: Nature communications, Vol. 10, Issue 1, pp. 3181, (2019) (PubMed).
: "Direct contact with perivascular tumor cells enhances integrin αvβ3 signaling and migration of endothelial cells." in: Oncotarget, Vol. 7, Issue 28, pp. 43852-43867, (2018) (PubMed).
: "cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells." in: Journal of controlled release : official journal of the Controlled Release Society, Vol. 261, pp. 275-286, (2018) (PubMed).
: "Soluble bone-derived osteopontin promotes migration and stem-like behavior of breast cancer cells." in: PLoS ONE, Vol. 12, Issue 5, pp. e0177640, (2017) (PubMed).
: "Plasma endothelial microparticles reflect the extent of capillaroscopic alterations and correlate with the severity of skin involvement in systemic sclerosis." in: Microvascular research, Vol. 110, pp. 24-31, (2017) (PubMed).
: "Ultrasound molecular imaging with cRGD-PLGA-PFOB nanoparticles for liver fibrosis staging in a rat model." in: Oncotarget, Vol. 8, Issue 65, pp. 108676-108691, (2017) (PubMed).
: "Analysis of Bone-Cartilage-Stromal Progenitor Populations in Trauma Induced and Genetic Models of Heterotopic Ossification." in: Stem cells (Dayton, Ohio), Vol. 34, Issue 6, pp. 1692-701, (2016) (PubMed).
: "GSH-sensitive Pt(IV) prodrug-loaded phase-transitional nanoparticles with a hybrid lipid-polymer shell for precise theranostics against ovarian cancer." in: Theranostics, Vol. 9, Issue 4, pp. 1047-1065, (2019) (PubMed).
: "β8 Integrin Mediates Pancreatic Cancer Cell Radiochemoresistance." in: Molecular cancer research : MCR, (2019) (PubMed).
: "The post-abscission midbody is an intracellular signaling organelle that regulates cell proliferation." in: Nature communications, Vol. 10, Issue 1, pp. 3181, (2019) (PubMed).
: "Direct contact with perivascular tumor cells enhances integrin αvβ3 signaling and migration of endothelial cells." in: Oncotarget, Vol. 7, Issue 28, pp. 43852-43867, (2018) (PubMed).
: "cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells." in: Journal of controlled release : official journal of the Controlled Release Society, Vol. 261, pp. 275-286, (2018) (PubMed).
: "Soluble bone-derived osteopontin promotes migration and stem-like behavior of breast cancer cells." in: PLoS ONE, Vol. 12, Issue 5, pp. e0177640, (2017) (PubMed).
: "Plasma endothelial microparticles reflect the extent of capillaroscopic alterations and correlate with the severity of skin involvement in systemic sclerosis." in: Microvascular research, Vol. 110, pp. 24-31, (2017) (PubMed).
: "Ultrasound molecular imaging with cRGD-PLGA-PFOB nanoparticles for liver fibrosis staging in a rat model." in: Oncotarget, Vol. 8, Issue 65, pp. 108676-108691, (2017) (PubMed).
: "Analysis of Bone-Cartilage-Stromal Progenitor Populations in Trauma Induced and Genetic Models of Heterotopic Ossification." in: Stem cells (Dayton, Ohio), Vol. 34, Issue 6, pp. 1692-701, (2016) (PubMed).
Aliases for CD51 抗体
integrin subunit alpha V (ITGAV) 抗体integrin alpha V (Itgav) 抗体
integrin subunit alpha V (Itgav) 抗体
1110004F14Rik 抗体
2610028E01Rik 抗体
CD51 抗体
Cd51 抗体
D430040G12Rik 抗体
MSK8 抗体
VNRA 抗体
VTNR 抗体
您还需要查找其他产品吗？
You are here:
